Sharing notes with patients: A review of current practice and considerations for neurologistsAuthors Respond:
Citation Manager Formats
Make Comment
See Comments

I read with interest the Yu et al.1 commentary on sharing office visit notes with patients. I often read aloud the last office visit notes to my patient at the time of the follow-up visit. I begin this by saying “this is what I documented when I last saw you. Please correct me if I got anything wrong in your history.” I have found this helpful in 2 ways. One, it helps to refresh the history, assessment, and plan in my own mind; and second, it helps engage the patient and accompanying caregiver in his or her care. My experience with this exercise has been a mixed bag. Some patients compliment me for documenting a comprehensive history, while others berate me for getting their hand dominance wrong, or documenting their alcohol intake or use of illicit drugs. Medicine is a science and you call a spade a spade. Alcoholism is not synonymous with social drinking and I fear that physicians would have to water down their notes just to avoid offending the patient. A physician's office notes should be an accurate, objective, and nonjudgmental documentation of the patient rather than a politically correct one. Finally, a physician should never forget that the office note is a medico-legal document, one that can be produced in court and at times used against him or her.
Disclosures:
N. Sethi serves as Associate Editor of The Eastern Journal of Neurology.
- © 2017 American Academy of Neurology
Authors Respond:
We thank Dr. Sethi for his comments on our article1 and for sharing his personal experience with open notes. We agree with his comments and want to emphasize that we do not advocate for watering down clinical documentation. The integrity of the clinical note for its primary purpose is paramount. In addition, although patients may be upset in the short term, calling a spade a spade when it comes to substance use, and the patient's viewing the documentation in the privacy of his or her own home may allow the patient to eventually overcome denial and take action. If a note is felt to be particularly sensitive, the provider should have the option to refrain from releasing the note to the patient as well.
Disclosures:
M.M. Yu has received funding for travel and/or speaker honoraria from the AAN and is a member of the Epic Neuroscience Steering Board. A.L. Weathers has received funding for travel and/or speaker honoraria from the AAN, North Carolina Neurologic Society, and Los Angeles Neurologic Society; serves on the Editorial Board of Continuum: Lifelong Learning in Neurology and serves as chair of the Adult Neuroscience Specialty Steering Board for Epic. A. Wu is a member of the Epic Neuroscience Steering Board; has received speaker honoraria from the AAN; serves on the Editorial Advisory Board for Neurology Now; serves on a scientific advisory board and the speakers' bureau for Novartis and Lundbeck; and receives research support from Novartis, Department of Defense/Congressionally Directed Medical Research Program, NIH, Tuberous Sclerosis Alliance, and Today's and Tomorrow's Children Fund. D. Evans serves on the speakers' bureau for and has received funding for travel and speaker honoraria from the AAN; serves on the editorial review board for MGMA Connection; and serves as Chief Executive Officer of Texas Neurology.
References
- 1.↵
- Yu MM,
- Weathers AL,
- Wu AD,
- Evans DA
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Alcohol use is a risk factor for a first generalized tonic-clonic seizureM. Leone, E. Bottacchi, E. Beghi et al.Neurology, March 01, 1997 -
Articles
Differential effects of cocaine and cocaine alcohol on neurocognitive performanceKaren I. Bolla, Frank R. Funderburk, Jean Lud Cadet et al.Neurology, June 27, 2000 -
Article
Risk factors for all-cause death after diagnosis of unruptured intracranial aneurysmsSeppo Juvela, Hanna Lehto et al.Neurology, January 07, 2015 -
Articles
Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson diseaseA. H. Evans, A. D. Lawrence, J. Potts et al.Neurology, November 21, 2005